Literature DB >> 24332364

A case of congenital Echovirus 11 infection acquired early in pregnancy.

M Tassin1, J Martinovic2, A Mirand3, H Peigue-Lafeuille3, O Picone4, A Benachi1, C Vauloup-Fellous5.   

Abstract

Enterovirus (EV) maternal infection during pregnancy and its relation to fetal developmental pathology are seldomly described. When reported, the main manifestations of EV congenital infections are myocarditis or intra-uterine fetal demise (IUFD). No information on intrauterine Echovirus 11 infection or the effect of transplacental Echovirus 11 infection on development of the fetus has been described in literature up to date (excluding late-pregnancy infections). We report here a case of an extreme form of pulmonary hypoplasia in a neonate, characterized by total failure of development of terminal respiratory units. This pregnancy was marked by spontaneous demise of a co-twin at 14 weeks of gestation (WG), as well as by positive PCR for EV (Echovirus 11 serotype) in the amniotic fluid, performed for moderate pericardial effusion at 22WG. No signs of cardiac disease were further observed, but at 32WG a bilateral abnormal lung development was noticed After spontaneous delivery at 38WG, the child could not be resuscitated, and died at one hour after birth. Pulmonary hypoplasia is usually described following decrease intrapulmonary pressure due to oligohydramnios or compression due to intrathoracic mass of variable cause. However, rare cases of primary pulmonary hypoplasia are also described and usually of unknown etiology. The coexistence in our case of a congenital EV infection and a severe primary pulmonary hypoplasia with congenital acinar aplasia, challenges our understanding of the pathogenesis of this severe pulmonary growth arrest.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Congenital acinar aplasia; Congenital infection; Enterovirus; Pulmonary hypoplasia

Mesh:

Year:  2013        PMID: 24332364     DOI: 10.1016/j.jcv.2013.11.003

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  7 in total

1.  The neonatal Fc receptor is a pan-echovirus receptor.

Authors:  Stefanie Morosky; Alexandra I Wells; Kathryn Lemon; Azia S Evans; Sandra Schamus; Christopher J Bakkenist; Carolyn B Coyne
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-11       Impact factor: 11.205

Review 2.  Viral infections during pregnancy.

Authors:  Michelle Silasi; Ingrid Cardenas; Ja-Young Kwon; Karen Racicot; Paula Aldo; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2015-01-13       Impact factor: 3.886

3.  Adverse effects of maternal enterovirus infection on the pregnancy outcome: a prospective and retrospective pilot study.

Authors:  Z Khediri; C Vauloup-Fellous; A Benachi; J M Ayoubi; L Mandelbrot; O Picone
Journal:  Virol J       Date:  2018-04-16       Impact factor: 4.099

4.  Clinical characteristics of severe neonatal enterovirus infection: a systematic review.

Authors:  Meng Zhang; Haoran Wang; Jun Tang; Yang He; Tao Xiong; Wenxing Li; Yi Qu; Dezhi Mu
Journal:  BMC Pediatr       Date:  2021-03-15       Impact factor: 2.125

Review 5.  Defining the Enterovirus Diversity Landscape of a Fecal Sample: A Methodological Challenge?

Authors:  Temitope Oluwasegun Cephas Faleye; Moses Olubusuyi Adewumi; Johnson Adekunle Adeniji
Journal:  Viruses       Date:  2016-01-12       Impact factor: 5.048

6.  Acute Transverse Myelitis Caused by Echovirus 11 in a Pediatric Patient: Case Report and Review of the Current Literature.

Authors:  Heidi L Moline; Peter I Karachunski; Anna Strain; Jayne Griffith; Cynthia Kenyon; Mark R Schleiss
Journal:  Child Neurol Open       Date:  2018-01-15

7.  Seasonality of the transmissibility of hand, foot and mouth disease: a modelling study in Xiamen City, China.

Authors:  Zehong Huang; Mingzhai Wang; Luxia Qiu; Ning Wang; Zeyu Zhao; Jia Rui; Yao Wang; Xingchun Liu; Mikah Ngwanguong Hannah; Benhua Zhao; Yanhua Su; Bin Zhao; Tianmu Chen
Journal:  Epidemiol Infect       Date:  2019-12-30       Impact factor: 2.451

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.